Danske Bank A/S Exact Sciences Corp Transaction History

Danske Bank A/S

  • $1.95 Trillion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025
BUY
$40.91 - $56.0 $122,729 - $168,000
3,000 New
3,000 $164,000
Q2 2025

Dec 18, 2025
SELL
$40.31 - $58.08 $3 Million - $4.32 Million
-74,359 Reduced 98.41%
1,200 $63,000
Q1 2025

Dec 18, 2025
BUY
$43.04 - $58.51 $3.12 Million - $4.25 Million
72,559 Added 2418.63%
75,559 $3.27 Million

Others Institutions Holding EXAS

# of Institutions
672
Shares Held
164M
Call Options Held
2.2M
Put Options Held
1.69M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Danske Bank A/S Portfolio

Follow Danske Bank A/S and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

News

Stay updated on Danske Bank A/S with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email